期刊文献+

血浆脂质成份与冠状动脉病变支数和程度的临床研究 被引量:1

The relationship between the plasma lipids and the severity of coronary artery lesions
下载PDF
导出
摘要 目的探讨血浆脂质成份与冠状动脉病变支数和程度的相关性。方法对疑诊冠状动脉粥样硬化性心脏病(简称冠心病)而作选择性冠状动脉造影的220例住院患者,进行血浆脂质成份的测定。结果冠状动脉病变患者的载脂蛋白B、非高密度脂蛋白-胆固醇、低密度脂蛋白-胆固醇与高密度脂蛋白-胆固醇、甘油三酯与冠状动脉无病变组患者比较,差别均有显著性意义(均P<0.05);经Spearman相关分析和逐步多元回归分析表明冠状动脉病变支数与载脂蛋白B相关,病变程度与脂蛋白(a)相关。结论提示血浆脂质成份中的载脂蛋白B、脂蛋白(a)可能是冠心病发生与发展中的相关因素,并具有重要的致动脉粥样硬化的作用。 Objective To investigate the relationship between the lipid parameters of plasma and the severity of coronary artery lesions. Methods A total of 220 admitted patients were studied retrospectively, all patients were suspected to have coronary artery disease and underwent a selective coronary angiography and a survey of lipid parameters of plasma during the hospitalization. Results The plasma apoB, non-HDL-C and TG levels were significantly higher in patients with positive coronary angiography than those with negative results. The spearman correlation analysis and stepwise regression analysis showed a significant correlation between Lp(a) level and the severity of the coronary artery lesions, between apoB level and the number of involved vessels. Conclusions ApoB and Lp(a) level may be the most correlated factor with the development and progression of cardiovascular atherosclerotic disease.
出处 《浙江医学》 CAS 2005年第3期173-175,共3页 Zhejiang Medical Journal
  • 相关文献

参考文献10

  • 1李健斋,王抒.浅议新修订的血脂水平划分方案[J].中华检验医学杂志,2001,24(5):261-262. 被引量:44
  • 2Bittner V, Hardison R, Kelsey SF, et al. Non-high-density lipoprotein cholesterol levels predict five-year outcome in the bypass angioplasty revascularization investigation (BARI). Circulation, 2002, 106(20): 2537. 被引量:1
  • 3Hirsch GA, Vaid N, Blumenthal RS. Prespectives: The significance of measuring non-HDL-cholesterol. Prey Cardiol, 2002,5(3):156. 被引量:1
  • 4Williams K, Sniderman AD, Sattar N,et al. Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation, 2003, 108(19):2312. 被引量:1
  • 5Austen WG, Edwars JE, Faye RI, et al. American heart association report: a reporting system in patients evaluated for coronary artery disease.report of the ad hoc committee for grading of coronary artery disease. Circulation, 1975, 51(1):7. 被引量:1
  • 6Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol, 1983, 51(2): 606. 被引量:1
  • 7Phillips NR, Waters D. Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical event. Circulation, 1993, 88(19): 2762. 被引量:1
  • 8Scott M, Low-density lipoprotein, non-high-density lipoprotein and apolipoprotein B as targets of lipid-lowering theeapy. Circulation, 2002, 106(20): 2526. 被引量:1
  • 9Marcel P, Michele C, Iannetta P, et al. Elevated serum lipoprotein(a) level is an independent marker of severity of thoracic aortic atherosclerosis. Chest, 2002, 121(5): 1589. 被引量:1
  • 10Grundy SM. Hypertriglyceridemia atherogenic dyslipidemia and the metabolic syndrome. Am J Cardiol, 1998, 81(4A): 18B. 被引量:1

二级参考文献2

  • 1中华心血管病杂志,1997年,25卷,169页 被引量:1
  • 2方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067

共引文献43

同被引文献14

  • 1胡良皞,秦永文.载脂蛋白对冠心病的风险预测[J].中国心血管病研究,2007,5(2):147-149. 被引量:5
  • 2Levenson JW,Skerrett PJ,Gaziano JM.Reducing the global burden of cardiovascular disease:the role of risk factors.Prey Cardiol,2002,5:188-199. 被引量:1
  • 3Executive Summary of the Third Report of the National Cholesterol Education Program(NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Cholesterol in Adult.JAMA,2001,285:2486-2497. 被引量:1
  • 4Wilson PWF,D'Agestino RB,Levy D,et al.Prediction of coronary heart disease using risk factor categories.Ciroulation,1998,97:1837-1847. 被引量:1
  • 5Conroy RM,Pyorala K,Fitzgerald AP,et al.Estimation of tenyear risk of fatal cardiovascular disease in Europe:the SCORE project.Eur Heart J,2003,24:987-1003. 被引量:1
  • 6Walldius G,Junger I,Hgolme I.High apolipoproteinB,low apolipoproteinAI,and improvement in the prediction of fatal myocardial infarction (AMORIS Study):a prospective study.Lancet,2001,358:2026-2033. 被引量:1
  • 7Lamarche B,Moorjani S,Lupien PJ,et al.Apolipoprotein A1 and B levels and the risk of ischemic heart disease during a five year follow-up of men in the Quebec Cardiovascular study.Circulation,1996,94:273-278. 被引量:1
  • 8Talmud PJ,Hawe E,Miller GJ,et al.Non-fasting apoB and triglyceride levels as a useful predictor of coronary hear disease risk in middle-aged UK men.Arterionseler Thromb Vase Biol,2002,22:1 918-923. 被引量:1
  • 9Sniderman AD,Furberg CD,Keech A,et al.Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.Lancet,2003,361:777-780. 被引量:1
  • 10Yusnf S,Hawken S,Ounpuu S,et al.On behalf of the INTERHEART study Investigators.Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study):cese-control study.Lancet,2004,364:937-952. 被引量:1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部